ArticleVirus research2026

Repurposing ALK inhibitors as influenza and corona virus antivirals targeting lymphocyte tyrosine kinase (LTK).

Elias Tjärnhage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.